Lumexa Imaging (LMRI) vs 10x Genomics (TXG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
10x Genomics is the larger company by market cap ($10.72 billion vs $1.02 billion), about 10.6 times the size. On valuation, Lumexa Imaging trades at a lower forward P/E (11.9x vs 1072.9x for 10x Genomics).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LMRI | TXG |
|---|---|---|
| Share price | $10.57 | $82.26 |
| Market cap | $1.02B | $10.72B |
| 1-day change | +2.32% | +6.44% |
| YTD return | -44.16% | +373.82% |
| 1-year return | — | +540.27% |
| 5-year return | — | -49.25% |
| Forward P/E | 11.87 | — |
| EPS (TTM) | $-0.37 | $-0.59 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $642.82M |
| Revenue growth (YoY) | — | +5.25% |
| Net income (latest FY) | — | $-43.54M |
| Gross margin | — | 69.05% |
| Operating margin | — | -9.49% |
| Net margin | — | -6.77% |
| 52-week high | $19.45 | $102.81 |
| 52-week low | $6.45 | $11.16 |
| Distance from 52-week high | -45.66% | -19.99% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +67.17% | -17.98% |
| Average volume | 430.76K | 3.29M |
| Shares outstanding | 96.07M | 120.21M |
| Employees | 5,000 | 1,178 |
| Sector | Health Care | Industrials |
| Industry | Medical Specialities | Biotechnology: Laboratory Analytical Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- 10x Genomics is about 10.6 times larger than Lumexa Imaging by market value ($10.72B vs $1.02B).
- The two companies sit in different sectors: Lumexa Imaging in Health Care and 10x Genomics in Industrials.
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
About 10x Genomics
TXG stock →10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
Industrials · Biotechnology: Laboratory Analytical Instruments · 1,178 employees
LMRI vs TXG FAQ
Which is bigger, Lumexa Imaging or 10x Genomics?
10x Genomics (TXG) is larger, with a market capitalization of $10.72B compared with $1.02B for Lumexa Imaging (LMRI).
Are Lumexa Imaging and 10x Genomics in the same industry?
No. Lumexa Imaging is in the Health Care sector, while 10x Genomics is in Industrials.